Results 1 to 10 of about 1,987,016 (297)
A framework for nationwide COVID-19 vaccine safety research in the Republic of Korea: the COVID-19 Vaccine Safety Research Committee [PDF]
Osong Public Health and Research Perspectives, 2023 With the introduction of coronavirus disease 2019 (COVID-19) vaccines, the Korea Disease Control and Prevention Agency (KDCA) commissioned the National Academy of Medicine of Korea to gather experts to independently assess post-vaccination adverse events.Na-Young Jeong, Hyesook Park, Sanghoon Oh, Seung Eun Jung, Dong-Hyun Kim, Hyoung-Shik Shin, Hee Chul Han, Jong-Koo Lee, Jun Hee Woo, Byung-Joo Park, Nam-Kyong Choi +10 moredoaj +1 more sourceModel-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant
Communications Medicine, 2021 Coutinho et al. use genomic and epidemiological data from Manaus, Brazil, to estimate the transmissibility and potential for reinfection with the SARS-CoV-2 variant-of-concern P.1 (gamma).Renato Mendes Coutinho, Flavia Maria Darcie Marquitti, Leonardo Souto Ferreira, Marcelo Eduardo Borges, Rafael Lopes Paixão da Silva, Otavio Canton, Tatiana P. Portella, Silas Poloni, Caroline Franco, Mateusz M. Plucinski, Fernanda C. Lessa, Antônio Augusto Moura da Silva, Roberto Andre Kraenkel, Maria Amélia de Sousa Mascena Veras, Paulo Inácio Prado +14 moredoaj +1 more sourceThe World Health Organization COVID-19 surveillance database
International Journal for Equity in Health, 2022 In January 2020, SARS-CoV-2 virus was identified as a cause of an outbreak in China. The disease quickly spread worldwide, and the World Health Organization (WHO) declared the pandemic in March 2020. From the first notifications of spread of the disease, Maya Allan, Maja Lièvre, Henry Laurenson-Schafer, Stéphane de Barros, Yuka Jinnai, Sophie Andrews, Thomas Stricker, Jesus Perez Formigo, Craig Schultz, Anne Perrocheau, Julia Fitzner +10 moredoaj +1 more sourceA cohort study measuring SARS-CoV-2 seroconversion and serial viral testing in university students
BMC Infectious Diseases, 2022 Background To improve understanding of the antibody response to SARS-CoV-2 infection, we examined seroprevalence, incidence of infection, and seroconversion among a cohort of young adults living on university campuses during the fall of 2020.Christine C. Lee, Hannah E. Segaloff, Devlin Cole, Hannah G. Rosenblum, Clint N. Morgan, Tarah Somers, Rodel Desamu-Thorpe, Monique A. Foster, Dustin Currie, Jeanne Ruff, David Payne, Thomas J. Whyte, Glen R. Abedi, John Paul Bigouette, Juliana Kahrs, Kimberly Langolf, Patrick Remington, Alana Sterkel, Patrick Kelly, Ryan P. Westergaard, Allen C. Bateman, Christopher H. Hsu, Jacqueline E. Tate, Hannah L. Kirking +23 moredoaj +1 more sourceAssessment of Anti-SARS-CoV-2 antibody levels among university students vaccinated with different COVID-19 primary and booster doses — fall 2021, Wisconsin
BMC Infectious Diseases, 2023 Background University students commonly received COVID-19 vaccinations before returning to U.S. campuses in the Fall of 2021. Given likely immunologic variation among students based on differences in type of primary series and/or booster dose vaccine ...Peter M. DeJonge, Anastasia S. Lambrou, Hannah E. Segaloff, Allen Bateman, Alana Sterkel, Carol Griggs, Jake Baggott, Patrick Kelly, Natalie Thornburg, Monica Epperson, Rodel Desamu-Thorpe, Glen Abedi, Christopher H. Hsu, Jasmine Y. Nakayama, Jasmine Ruffin, Darlene Turner-Harper, Almea Matanock, Olivia Almendares, Melissa Whaley, Ayan Chakrabarti, Kyle DeGruy, Michele Daly, Ryan Westergaard, Jacqueline E. Tate, Hannah L. Kirking +24 moredoaj +1 more sourceHarnessing peak transmission around symptom onset for non-pharmaceutical intervention and containment of the COVID-19 pandemic
Nature Communications, 2021 Transmission by pre-symptomatic and asymptomatic viral carriers makes intervention and containment of the COVID-19 extremely challenging. Here, the authors construct an epidemiological model that focuses on transmission around the symptom onset ...Liang Tian, Xuefei Li, Fei Qi, Qian-Yuan Tang, Viola Tang, Jiang Liu, Zhiyuan Li, Xingye Cheng, Xuanxuan Li, Yingchen Shi, Haiguang Liu, Lei-Han Tang +11 moredoaj +1 more sourceCountries with delayed COVID-19 introduction – characteristics, drivers, gaps, and opportunities
Globalization and Health, 2021 Background Three months after the first reported cases, COVID-19 had spread to nearly 90% of World Health Organization (WHO) member states and only 24 countries had not reported cases as of 30 March 2020. This analysis aimed to 1) assess characteristics, Zheng Li, Cynthia Jones, Girum S. Ejigu, Nisha George, Amanda L. Geller, Gregory C. Chang, Alys Adamski, Ledor S. Igboh, Rebecca D. Merrill, Philip Ricks, Sara A. Mirza, Michael Lynch +11 moredoaj +1 more sourceCOVID-19 in Older Individuals Requiring Hospitalization
Infectious Disease Reports, 2022 Older individuals have an increased risk for severe coronavirus disease 2019 (COVID-19) and a higher risk for complications and death. The aim of this study was to investigate the clinical characteristics of older patients admitted with COVID-19 and ...Petros Ioannou, Despoina Spentzouri, Myrto Konidaki, Michalis Papapanagiotou, Sotiris Tzalis, Ioannis Akoumianakis, Theodosios D. Filippatos, Symeon Panagiotakis, Diamantis P. Kofteridis +8 moredoaj +1 more sourceDifferential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines
Nature Communications, 2022 Emerging SARS-CoV-2 variants raise concerns on immune evasion. Here, the authors evaluate the neutralization efficiency of COVID-19 mRNA vaccinee sera against representative viruses of 13 WHO-designated SARS-CoV-2 variants of concern/interest.Li Wang, Markus H. Kainulainen, Nannan Jiang, Han Di, Gaston Bonenfant, Lisa Mills, Michael Currier, Punya Shrivastava-Ranjan, Brenda M. Calderon, Mili Sheth, Brian R. Mann, Jaber Hossain, Xudong Lin, Sandra Lester, Elizabeth A. Pusch, Joyce Jones, Dan Cui, Payel Chatterjee, M. Harley Jenks, Esther K. Morantz, Gloria P. Larson, Masato Hatta, Jennifer L. Harcourt, Azaibi Tamin, Yan Li, Ying Tao, Kun Zhao, Kristine Lacek, Ashley Burroughs, Wei Wang, Malania Wilson, Terianne Wong, So Hee Park, Suxiang Tong, John R. Barnes, Mark W. Tenforde, Wesley H. Self, Nathan I. Shapiro, Matthew C. Exline, D. Clark Files, Kevin W. Gibbs, David N. Hager, Manish Patel, Alison L. Halpin, Laura K. McMullan, Justin S. Lee, Hongjie Xia, Xuping Xie, Pei-Yong Shi, C. Todd Davis, Christina F. Spiropoulou, Natalie J. Thornburg, M. Steven Oberste, Vivien G. Dugan, SSEV Bioinformatics Working Group, David E. Wentworth, Bin Zhou +56 moredoaj +1 more sourceErectile Dysfunction and COVID-19: a Case Report
Jurnal Profesi Medika, 2021 Coronavirus Diesease-2019 (COVID-19) infection is suspected to affect the sexual behavior and function. The vascular damage related to COVID-19 can affect the impairment of bed blood vessel of penile and finally make the erectile dysfunction (ED).Gembong Satria Mahardhika, Nastiti Maharani, Theodore Dharma Tedjamartono, Efriadi Ismail +3 moredoaj +1 more source